Carna Biosciences Inc. | Balance Sheet
Fiscal year is January-December. All values JPY Millions.
2013
2014
2015
2016
2017
Cash & Short Term Investments
1,068
627
1,625
2,161
1,856
Total Accounts Receivable
120
95
192
123
92
Inventories
119
119
125
122
118
Other Current Assets
55
66
54
87
68
Total Current Assets
1,361
908
1,996
2,493
2,134
Net Property, Plant & Equipment
36
53
37
35
20
Total Investments and Advances
193
241
286
-
-
Intangible Assets
-
282
2
1
1
Other Assets
17
18
17
38
35
Total Assets
1,889
1,221
2,338
2,566
2,190
ST Debt & Current Portion LT Debt
36
39
65
170
182
Accounts Payable
4
4
15
3
3
Income Tax Payable
10
7
39
5
19
Other Current Liabilities
79
145
116
93
138
Total Current Liabilities
130
196
236
271
342
Long-Term Debt
104
122
148
527
442
Provision for Risks & Charges
-
25
25
26
26
Deferred Taxes
31
47
57
-
-
Other Liabilities
26
2
1
2
2
Total Liabilities
291
391
467
827
812
Common Equity (Total)
1,598
830
1,871
1,739
1,378
Total Shareholders' Equity
1,598
830
1,871
1,739
1,378
Total Equity
1,598
830
1,871
1,739
1,378
Liabilities & Shareholders' Equity
1,889
1,221
2,338
2,566
2,190
About Carna Biosciences
View Profile
